Deirdre Lane
Deirdre Lane
University of Liverpool, United Kingdom; Aalborg University, Denmark
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 131 (4), e29-e322, 2015
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial …
GYH Lip, R Nieuwlaat, R Pisters, DA Lane, HJGM Crijns
Chest 137 (2), 263-272, 2010
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey
R Pisters, DA Lane, R Nieuwlaat, CB De Vos, HJGM Crijns, GYH Lip
Chest 138 (5), 1093-1100, 2010
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with …
Authors/Task Force Members, SG Priori, C Blomström-Lundqvist, ...
Ep Europace 17 (11), 1601-1687, 2015
American Heart Association Council on epidemiology and prevention statistics committee and stroke statistics subcommittee
EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ...
Heart disease and stroke statistics-2018 update: a report from the American …, 2018
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ...
Ep Europace 17 (10), 1467-1507, 2015
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
J Steffel, P Verhamme, TS Potpara, P Albaladejo, M Antz, L Desteghe, ...
European heart journal 39 (16), 1330-1393, 2018
Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice …
JJ You, DE Singer, PA Howard, DA Lane, MH Eckman, MC Fang, ...
Chest 141 (2), e531S-e575S, 2012
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver …
GYH Lip, L Frison, JL Halperin, DA Lane
Journal of the American College of Cardiology 57 (2), 173-180, 2011
Stroke and bleeding in atrial fibrillation with chronic kidney disease
JB Olesen, GYH Lip, AL Kamper, K Hommel, L Køber, DA Lane, ...
New England Journal of Medicine 367 (7), 625-635, 2012
Quality of life in patients with atrial fibrillation: a systematic review
G Thrall, D Lane, D Carroll, GYH Lip
The American journal of medicine 119 (5), 448. e1-448. e19, 2006
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a …
Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ...
European heart journal 35 (45), 3155-3179, 2014
Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety
D Lane, D Carroll, C Ring, DG Beevers, GYH Lip
Psychosomatic medicine 63 (2), 221-230, 2001
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation …
GYH Lip, L Frison, JL Halperin, DA Lane
Stroke 41 (12), 2731-2738, 2010
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The …
G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ...
European heart journal 42 (5), 373-498, 2021
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort study
JB Olesen, GYH Lip, J Lindhardsen, DA Lane, O Ahlehoff, ML Hansen, ...
Thrombosis and haemostasis 106 (10), 739-749, 2011
Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report
GYH Lip, A Banerjee, G Boriani, C en Chiang, R Fargo, B Freedman, ...
Chest 154 (5), 1121-1201, 2018
Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The …
S Apostolakis, DA Lane, Y Guo, H Buller, GYH Lip
Journal of the American College of Cardiology 60 (9), 861-867, 2012
Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
DA Lane, GYH Lip
Circulation 126 (7), 860-865, 2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20